Earnings History Data for Kalaris Therapeutics Inc. (KLRS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent diseases of the retina. Kalaris Therapeutics Inc., formerly known as AlloVir Inc., is based in PALO ALTO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-05-2025 | PM | KLRS | Kalaris Therapeutics Inc. | 17.00 | -2.52 | -0.78 | 0.00 | Kalaris Therapeutics, Inc. reports Q1 results [5/14/2025 8:54 AM] |
3.32 | 0.07 (2.15%) |
3.29 | 0.04 (1.23%) |
3.10 - 24.15 | 66,866 | 50,000 | 662 | ||